At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Mar 23, 2026 at 16:13 ET
Analysis based on filing metadata only, document content was unavailable
- Filing is a DEFA14A (Definitive Additional Materials) for a proxy statement
- Filed by Halozyme Therapeutics, Inc. (HALO)
- No financial data or specific event details available in provided documents
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access